McCue Corporation was established in 1991 with a view to creating a new internationally based organization specializing in instrumentation technology. The company owns the Intellectual Property and Proprietary Rights to a unique medical system designed to measure bone quality. The product "CUBAClinical" is a low cost, safe and, effective ultrasound system, which represents a major breakthrough for the clinical diagnosis of brittle bones and fracture risk, which is the ultimate manifestation of the disease commonly known as Osteoporosis. It is estimated that Osteoporosis occurs in one in three postmenopausal caucasian women worldwide and that 77% of these individuals are undiagnosed.

McCue Corporation Inc is based in Florida and Rhode Island and distributes the company's products in North America.

The McCue group is well funded and will grow rapidly to become a quality business recognized throughout the world for the performance and reliability of their products and for the sponsorship of technology for the benefit of all.

Approvals:

The Company is approved to ISO BS EN 9001:1994 and the Quality management systems and technical files relating to the CUBAClinical are approved in accordance with the Medical Device Directive 93/42/EEC.

The CUBAClinical received FDA approval on January 7th 2000 for use in the United States of America.